交易笔记
顶级投资人

顶级投资人

Warren BuffettCathie WoodLi LuRay DalioBill Ackman查看全部顶级投资人
历史归档
行业

AI & Compute

Semiconductors & AcceleratorsCloud & AI PlatformsData Center & NetworkingView all AI & Compute
研究
EN

TOIIW

The Oncology Institute, Inc.

Insider Trades

NameValueActionPriceCurrent Price
CJChernett Jorey10 Percent Owner
$57k12k shares
BuyJun 4, 2026
$4.75
--
CJChernett Jorey10 Percent Owner
$136k33.5k shares
BuyMay 20, 2026
$4.07
--
CJChernett Jorey10 Percent Owner
$123k30k shares
BuyMay 19, 2026
$4.09
--
CJChernett Jorey10 Percent Owner
$20k5k shares
BuyMay 19, 2026
$4.05
--
KMKaushal MohitDirector
$135k38.4k shares
SellApr 16, 2026
$3.50
--
KMKaushal MohitDirector
$201k57.3k shares
SellApr 14, 2026
$3.50
--
Trade TOIIW

About The Oncology Institute, Inc.

The Oncology Institute, Inc. operates as a U.S.-based firm, specializing in providing extensive medical oncology services. Its comprehensive offerings encompass direct physician care, integrated on-site infusion and pharmacy services, clinical research initiatives, outpatient stem cell transplant and transfusion programs, and dedicated patient support. The company also oversees and manages specialized programs, including palliative care and stem cell transplants, specifically designed to meet the needs of cancer patients. Established in 2007, its headquarters are located in Cerritos, California.

CEO
Daniel Virnich
IPO Date
Nov 12, 2021

Market Data

OpenThe first traded price for the current trading session.
$0.1817
HighThe highest traded price in the current trading session.
$0.1817
LowThe lowest traded price in the current trading session.
$0.0544
VolumeTotal shares traded during the current trading session.
17.4K
52W HighThe highest traded price over the past 52 weeks.
$0.1817
52W LowThe lowest traded price over the past 52 weeks.
$0.0544

Valuation

Market CapCompany equity value based on share price multiplied by shares outstanding.
$5.9M
Enterprise ValueMarket cap plus debt and other claims, less cash and equivalents.
$492M

Financials

Free Cash FlowOperating cash flow minus capital expenditures from the latest annual cash flow statement.
$-28M
RevenueTotal sales from the latest annual income statement.
$503M
Net IncomeProfit after expenses and taxes from the latest annual income statement.
$-61M
CashCash and equivalents, or cash plus short-term investments, from the latest balance sheet.
$34M
DebtTotal debt from the latest balance sheet.
$104M

Events

EarningsAug 11

EPS est. -0.065

现代市场行业

AI & Compute

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking

Software & Digital

  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

Healthcare

  • GLP-1 & Metabolic Health
  • Biotech & Oncology
  • Medical Devices & Diagnostics
  • Healthcare Services
  • Pharmaceuticals

Finance & Energy

  • Banks & Capital Markets
  • Asset Management & Exchanges
  • Insurance
  • Payments & Fintech
  • Digital Assets
  • Oil, Gas & Fuels

现代分类

  • AI & Compute Infrastructure
  • Software & Digital Platforms
  • Healthcare Innovation
  • Financial Infrastructure
  • Energy & Grid

细分行业

  • Semiconductors & Accelerators
  • Cloud & AI Platforms
  • Data Center & Networking
  • Enterprise Software
  • Cybersecurity
  • DevTools & Observability
  • Consumer Internet & Marketplaces
  • Digital Advertising & Media

动作类型

  • 投资人调仓
  • 高管交易
  • 国会交易
  • 股票动向

浏览

  • 历史归档
  • 行业
  • 分类
  • 顶级投资人
  • 关注列表
© 2026 交易笔记
历史归档行业分类顶级投资人关注列表